You are here

Validation of Molecular Diagnostic Thecnologies for Lung Cancer Patients.

Last updated on March 15, 2019

FOR MORE INFORMATION
Study Location
Centro Regional Integrado de Oncologia
Fortaleza, Caera, 60336-550 Brazil
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Lung Neoplasms
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Female or male, 18 years of age or older.

- Patients with histologically or cytological proven diagnosis of NSCLC, pathologically
identified as adenocarcinoma.

- Patient naïve in lung cancer treatment

- Signed and dated informed consent document indicating that the patient (or legally
acceptable representative) has been informed of all the pertinent aspects of the study
prior to enrollment.

- Patients must give consent to the research use of their archived or tumor FFPE tissue,
and if available, 2 blood tubes.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Prior chemotherapy treatment.

NCT03220230
Pfizer
Completed
Validation of Molecular Diagnostic Thecnologies for Lung Cancer Patients.

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now